|
Press Releases |
|
|
|
Tuesday, October 3, 2023 |
|
HanchorBio Announces First Patient Dosed in the Phase 1 Multi-Regional Clinical Trial of HCB101 |
more info >> |
|
Monday, August 28, 2023 |
|
HanchorBio and Henlius Announce Strategic Collaboration to Develop Innovative Immunotherapies |
HanchorBio and Henlius Announce Strategic Collaboration to Develop Innovative Immunotherapies more info >> |
|
HanchorBio and Henlius Announce Strategic Collaboration to Develop Innovative Immunotherapies |
HanchorBio and Henlius Announce Strategic Collaboration to Develop Innovative Immunotherapies more info >> |
|
Monday, July 24, 2023 |
|
HanchorBio Announces Taiwan FDA IND Approval for the Multi-Regional Clinical Trial of HCB101 to Treat Solid and Hematological Malignancies |
HanchorBio Inc., a global clinical-stage biotechnology company developing innovative immuno-biomedicines, announced today that the Taiwan Food and Drug Administration (TFDA) has approved its investigational new drug (IND) application to initiate a multi-regional clinical trial of its independently-developed novel drug candidate, HCB101, for the treatment of patients with advanced solid tumors or relapsed and refractory non-Hodgkin lymphoma. more info >> |
|
HanchorBio Announces Taiwan FDA IND Approval for the Multi-Regional Clinical Trial of HCB101 to Treat Solid and Hematological Malignancies |
HanchorBio Inc., a global clinical-stage biotechnology company developing innovative immuno-biomedicines, announced today that the Taiwan Food and Drug Administration (TFDA) has approved its investigational new drug (IND) application to initiate a multi-regional clinical trial of its independently-developed novel drug candidate, HCB101, for the treatment of patients with advanced solid tumors or relapsed and refractory non-Hodgkin lymphoma. more info >> |
|
Monday, April 17, 2023 |
|
HanchorBio Announces US IND Clearance for the Multi-Regional Clinical Trial of HCB101 to Treat Solid and Hematological Malignancies |
HanchorBio Inc., a global clinical-stage biotechnology company developing innovative immuno-biomedicines, announced today that the US. Food and Drug Administration (FDA) has cleared its investigational new drug (IND) application to initiate a multi-regional clinical trial of its independently-developed novel drug candidate, HCB101, for the treatment of patients with advanced solid tumors or relapsed and refractory non-Hodgkin lymphoma. more info >> |
|
HanchorBio Announces US IND Clearance for the Multi-Regional Clinical Trial of HCB101 to Treat Solid and Hematological Malignancies |
more info >> |
|
|
|
|
|
|
|
|
Latest Press Releases |
|
SDAI Limited: Positive Outcomes Since New Board took over in June 2023
May 2, 2024 20:00 HKT/SGT
|
|
|
Rockbird media Presents Retail & E-commerce Summit Asia 2024 - 'Retail Revolution: Setting the Landscape Ablaze' in Manila
May 2, 2024 19:49 HKT/SGT
|
|
|
Rockbird media Presents HR Leaders & HR Tech Strategy Meeting 2024: 'Rehumanizing Work with Emerging Technologies' in Manila
May 2, 2024 19:47 HKT/SGT
|
|
|
Itronics Announces Launch of New Website by Its Subsidiary Auric Gold & Minerals, Inc.
May 2, 2024 19:13 HKT/SGT
|
|
|
CleverTap launches Clever.AI, the AI-Driven Edge for Customer Engagement & Retention
May 2, 2024 18:00: JST
|
|
|
富通保險宣佈聯乘大灣區醫療集團及廣州市第一人民醫院南沙醫院
May 2, 2024 17:11 HKT/SGT
|
|
|
Four-strong TOYOTA GAZOO Racing squad to push for more Portugal success
May 2, 2024 18:05 JST
|
|
|
CleverTap launches Clever.AI, the AI-Driven Edge for Customer Engagement & Retention
May 2, 2024 17:00 HKT/SGT
|
|
|
Spectacular Spa awaits TOYOTA GAZOO Racing
May 2, 2024 17:46 JST
|
|
|
CyberSecID Conference 2024 - Zero Trust for Today, Zero Worries for Tomorrow
May 2, 2024 16:34: JST
|
|
|
CyberSecID Conference 2024 - Zero Trust for Today, Zero Worries for Tomorrow
May 2, 2024 15:34 HKT/SGT
|
|
|
World Blockchain Summit: Pioneering Insights and Strategic Partnerships Ignite in Dubai
May 2, 2024 13:35 HKT/SGT
|
|
|
韓国1位の成人教育分野企業のファストキャンパス、日本への新事業参入に本格化
May 2, 2024 13:00: JST
|
|
|
Future of Video in India Sees Much Optimism for Growth with Technology as the Enabler for the Consumer
May 2, 2024 13:00 HKT/SGT
|
|
|
Tex Cycle Partners with Evolusi Bersatu to Launch Sabah's First Integrated Scheduled Waste Management Facility
May 2, 2024 12:33 HKT/SGT
|
|
|
|
More News >> |
|
|
|
|
|